[1]郝丽君 综述 史小荣※①审校.宫腔镜手术前宫颈软化的研究进展[J].中国微创外科杂志,2019,01(2):178-181.
点击复制

宫腔镜手术前宫颈软化的研究进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2019年2期
页码:
178-181
栏目:
文献综述
出版日期:
2019-02-25

文章信息/Info

作者:
郝丽君 综述 史小荣※①审校
（山西医科大学第一临床医学院，太原030001）
文献标志码:
A

参考文献/References:

[1]冯力民,王稚晖,王伟娟，等.米索前列醇用于宫腔镜检查和手术的临床观察.中国实用妇科与产科杂志,2002,18(11):685-686.
[2]Xu D,Zhang X,He J.A prospective, randomized comparison of intramuscular phloroglucinol versus oral misoprostol for cervix pretreatment before diagnostic hysteroscopy.Int Surg,2015,100(7-8):1207-1211.
[3]Song T,Kim MK,Kim ML,et al.Effectiveness of different routes of misoprostol administration before operative hysteroscopy:a randomized,controlled trial.Fertil Steril,2014,102(2):519-524.
[4]Bastu E,Celik C,Nehir A,et al.Cervical priming before diagnostic operative hysteroscopy in infertile women: a randomized, doubleblind, controlled comparison of 2 vaginal misoprostol doses.Int Surg,2013,98(2):140-144.
[5]Tanha FD,Salimi S,Ghajarzadeh M.Sublingual versus vaginal misoprostol for cervical ripening before hysteroscopy:a randomized clinical trial.Arch Gynecol Obstet,2013,287(5):937-940.
[6]Saha M,Chakraborty A,Chattopadhyay S,et al.Effect of misoprostol for cervical priming before gynecological procedures on nonpregnant premenopausal women.J Nat Sci Biol Med,2015,6(Suppl 1):S123-S127.
[7]Mohammadian S, Tavana A, Tavana S,et al.Cervical priming by misoprostol before diagnostic dilatation and curettage:a randomized clinical trial.J Reprod Infertil，2015,16(3):162-166.
[8]Hua Y,Zhang W,Hu X,et al.The use of misoprostol for cervical priming prior to hysteroscopy:a systematic review and analysis.Drug Des Devel Ther，2016，10:2789-2801.
[9]王海波.米索前列醇应用于宫腔镜检查预处理265例效果评价.中国妇幼保健,2013,28(13):2156-2161.
[10]刘亚静,邬玺钻,李红云,等.缩宫素联合米索前列醇预防产后出血的临床效果观察.中国生化药物杂志,2016,36(3):37-39.
[11]杨德红,李燕茹.两种不同药物预处理对子宫粘膜下肌瘤患者手术指标、宫颈扩张程度及不良反应的影响.中国现代医学志,2017,27(11):59-62.
[12]Shin HJ,Lee SR,Roh AM,et al.Anaphylactic shock to vaginal misoprostol:a rare adverse reaction to a frequently used drug.Obstet Gynecol Sci,2018,61(5):636-640.
[13]Béné J,Alarcon P,Faucon M,et al.Anaphylactic shock after misoprostol in voluntary termination of pregnancy:a case report.Eur J Obstet Gynecol Reprod Biol,2014,182:260-261.
[14]左越,李红霞,蔡巧生,等.宫腔镜下切除子宫巨大壁间内突肌瘤1例报告.中国微创外科杂志,2017,17（4）:376-378.
[15]Hou MY.Uncomplicated abortion with mifepristone and misoprostol in a hemophilia A carrier．Contraception,2016,94(2)：187-189．
[16]Sun Y,Fang M,Davies H,et al.Mifepristone:a potential clinical agent based on its antiprogesterone and antiglucocorticoid properties.Gynecol Endocrinol,2014,30(3):169-173．
[17]沈奕,原玮,曹树军,等.非孕妇女口服米非司酮软化宫颈的作用及其机制探讨.药学服务与研究,2010,10(3):190-193.
[18]单春霞.米非司酮在宫腔镜检查中软化宫颈的效果分析.中国内镜杂志,2014,20（8）:887-888.
[19]胡浩梅．米非司酮配伍米索前列醇及一次性宫颈扩张棒终止12～18周妊娠的临床观察．中国计划生育和妇产科,2012,4（1）:33-35.
[20]Renner RM,Nichols MD,Jensen JT,et al.Paracervical block for pain control in firsttrimester surgical abortion:a randomized controlled trial.Obstet Gynecol,2012,119(5):1030-1037.
[21]耿可亭,谢柳云,陶小君,等．普瑞达一次性宫颈扩张棒宫颈扩张效果临床研究．中国妇幼保健,2015,30(1)：101-103．
[22]韩春艳,吴永红,邹文清.一次性宫颈扩张棒在绝经后妇女取器术中的应用.中国计划生育学杂志,2013,21（1）:57-58.
[23]向清华,黄伟,李春妮,等.宫腔镜手术患者应用一次性宫颈扩张棒预处理的效果观察.护理学报,2017,24（11）:49-51.
[24]王浩.普瑞达一次性宫颈扩张棒用于人工流产的疗效观察.河北医药,2015,37(14):2159-2160.
[25]Louvel D,Delvaux M,Staumout G,et al.Intracolonic injection of glycerol:a model for abdominal pain in irritable bowel syndrome?Gastroenterology,1996,110(2):351-361.
[26]Chassany O,Bonaz B,Bruley Des Varannes S,et al.Acute exacerbation of pain in irritable bowel syndrome:efficacy of phloroglucinol/trimethylphloroglucinol.a randomized,doubleblind,placebo controlled study.Aliment Pharmacol Ther,2007,25(9):1115-1123.
[27]蔡妮.间苯三酚用于宫腔镜术前宫颈软化效果观察.海南医学,2015,26(9):1354-1355.
[28]刘素芬,施如霞,谢晔玲.间苯三酚和海藻宫颈扩张棒在宫腔镜手术中的应用.实用临床医药杂志,2015,19(13):176-177.
[29]孙景丽,王青,高绍凤,等.间苯三酚与米索前列醇在宫腔镜术前促宫颈成熟效果比较的Meta分析.中国内镜杂志,2016,22（6）:72-77.
[30]Zhuang Y,Zhu X,Huang L.The effect of phloroglucinol on pain in firsttrimester surgical abortion:a doubleblind randomized controlled study.Contraception,2010,81(2):157-160.
[31]Dickinson JE,Jennings BG,Doherty DA.Mifepristone and oral,vaginal,or sublingual misoprostol for secondtrimester abortion：a randomized controlled trial.Obstet Gynecol,2014,123（6）:1162-1168.
[32]汪沙,段华,付凤仙,等.卡前列甲酯用于子宫腔疾病诊断术前宫颈预处理的疗效观察.中国计划生育和妇产科,2013,5(5):33-42.
[33]张凤芝,王宝金,白桦,等.卡前列甲酯栓在宫腔镜检查中给药时间探讨.中国妇幼保健,2013,28(35):5895-5896.
[34]汪邦兰,盛佳佳.一次性宫颈扩张棒联合卡前列甲酯栓用于人工流产术效果观察.安徽医学,2014,35(3):332-334.
[35]Hou SP,Chen OJ,Huang LH,et al.Medical methods for cervical ripening before the removal of intrauterine devices in postmenopausal women:a systematic review.Eur J Obstet Gynecol Reprod Biol,2013,169(2):130-142.
[36]Farber MK,Schultz R,Lugo L,et al.The effect of coadministration of intravenous calcium chloride and oxytocin on maternal hemodynamics and uterine tone following cesarean delivery:a doubleblinded,randomized,placebocontrolled trial.Int Obstet Anesth,2015,24(3):217-224.
[37]吕晓廷,李娟,尹智华.卡前列甲酯栓软化宫颈效果Meta分析.中国实用妇科与产科杂志,2017,33（9）:979-984.
[38]欧阳方贵,范湘玲.卡孕栓在宫腔镜手术前的应用效果.医学临床研究,2017,34(3):603-605.

备注/Memo

备注/Memo:
※通讯作者，Email：sxrglj123456888@163.com①（山西医科大学第一医院妇科，太原030001）
更新日期/Last Update: 2019-04-28